(E)‐4‐(4‐Chloro­phenyl)‐N‐(5‐methyl‐1,3‐benzo­dioxol‐5‐yl­methylene)‐5‐(1H‐1,2,4‐triazol‐1‐yl)‐1,3‐thia­zol‐2‐amine

By  

Acta Crystallographica Section E, Vol. 62, Iss. 1, 2006-01 ,pp. : o334-o335

John Wiley & Sons Inc

Access to resources Recommend Favorite

2‐Amino‐4‐(2,5‐di­chloro­phenyl)‐5‐(1H‐1,2,4‐triazol‐1‐yl)‐1,3‐thia­zole

By  

Acta Crystallographica Section E, Vol. 60, Iss. 12, 2004-12 ,pp. : o2517-o2519

John Wiley & Sons Inc

Access to resources Recommend Favorite

N‐[4‐Ferrocenyl‐5‐(1H‐1,2,4‐triazol‐1‐yl)‐1,3‐thia­zol‐2‐yl]‐2‐nitro­benzamide

By  

Acta Crystallographica Section E, Vol. 62, Iss. 1, 2006-01 ,pp. : m49-m51

John Wiley & Sons Inc

Access to resources Recommend Favorite

3‐(2‐Bromo‐5‐methoxy­phen­yl)‐5‐methyl‐1‐(4‐phenyl‐1,3‐thia­zol‐2‐yl)‐1H‐1,2,4‐triazole

By  

Acta Crystallographica Section E, Vol. 62, Iss. 11, 2006-11 ,pp. : o5013-o5014

John Wiley & Sons Inc

Access to resources Recommend Favorite

O,O‐Diethyl [({1‐[(2‐chloro­thia­zol‐5‐yl)meth­yl]‐5‐methyl‐1H‐1,2,3‐triazol‐4‐yl}carbon­yloxy)phenyl­meth­yl]phospho­nate

By  

Acta Crystallographica Section E, Vol. 63, Iss. 1, 2007-01 ,pp. : o158-o160

John Wiley & Sons Inc

Access to resources Recommend Favorite